Xxec, Inc. Abbott Laboratories Transaction History

Xxec, Inc.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 02, 2023	BUY	$95.06 - $111.52 $17,871 - $20,965	188 Added 2.16%	8,909 $978,000
Q3 2022 Nov 04, 2022	SELL	$96.76 - $112.03 $19,352 - $22,406	-200 Reduced 2.24%	8,721 $844,000
Q2 2022 Jul 26, 2022	SELL	$102.07 - $123.37 $74,204 - $89,689	-727 Reduced 7.54%	8,921 $969,000
Q1 2022 Apr 12, 2022	SELL	$114.02 - $139.04 $1,140 - $1,390	-10 Reduced 0.1%	9,648 $1.19 Million
Q3 2021 Oct 19, 2021	BUY	$116.66 - $129.06 $66,846 - $73,951	573 Added 6.31%	9,658 $1.14 Million
Q2 2021 Aug 13, 2021	SELL	$105.79 - $124.53 $27,082 - $31,879	-256 Reduced 2.74%	9,085 $1.05 Million
Q1 2021 Apr 16, 2021	BUY	$108.84 - $128.23 $2,285 - $2,692	21 Added 0.23%	9,341 $1.12 Million
Q4 2020 Feb 17, 2021	SELL	$105.0 - $114.42 $70,875 - $77,233	-675 Reduced 6.75%	9,320 $1.02 Million
Q3 2020 Oct 21, 2020	BUY	$91.64 - $111.29 $915,941 - $1.11 Million	9,995 New	9,995 $1.09 Million

3,185

1.3B

8.74M

8.08M

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $205B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

Get notified when there are updates to the investment portfolio of Xxec, Inc., based on Form 13F filings with the SEC.

Stay updated on Xxec, Inc. with notifications on news.